Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2026
Novo Nordisk launches once-daily Wegovy weight-loss pill in the US
Novo Nordisk launched the once-daily pill version of its weight-loss drug Wegovy in the United States on Monday, following FDA approval in December 2025. The pill is priced at $199-$299 per month and will be sold through US pharmacies including Costco and CVS and telehealth providers such as Ro, LifeMD, WeightWatchers, GoodRx and NovoCare Pharmacy.
2021
FDA approves Wegovy for chronic weight management
The U.S. Food and Drug Administration approved Wegovy, a higher-dose version of semaglutide, for chronic weight management in adults with obesity or overweight who meet the stated criteria.